💊 Get Accurate, Objective, and Timely Intelligence From DrugPatentWatch
Profile for Sangamo BioSciences, Inc. (SGMO)
« Back to company indexSGMO Chatter Timeline
Stock Ticker for SGMO
Most Active Tweeters for SGMO
| User | Tweets |
|---|---|
| @BiotechAnalysst | 12 |
| @mchilberg | 8 |
| @mattyjc | 3 |
| @TradeWithAlerts | 3 |
| @MarcJacksonLA | 2 |
Recent Tweets for SGMO
 |
@Gambiste1 RT @wkissel: $SGMO Pfizer and Sangamo re-open PhIII of hemophilia A gene therapy; AEON headed to PhIII - https://t.co/aVWTLen5vb September 24th 2022, 1:09am |
 |
@wkissel $SGMO Pfizer and Sangamo re-open PhIII of hemophilia A gene therapy; AEON headed to PhIII - https://t.co/aVWTLen5vb September 24th 2022, 12:09am |
 |
@Tickeron $SGMO in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/NyGLuBM6T9 September 23rd 2022, 9:09pm |
 |
@TradeWithAlerts Nice print for $SGMO Size: 239390 Price: 4.95 Amount: $1,184,980.50 Time: 1600 See more: https://t.co/hnsHyqewlx Jo… https://t.co/ua5J63XJqN September 23rd 2022, 8:09pm |
 |
@MarcJacksonLA $PFE $SGMO Months after exiting clinical hold, Pfizer readies to resume dosing in phase 3 gene therapy trial https://t.co/LojIdpJCHq September 23rd 2022, 2:09pm |
 |
@john_bresnahan RT @BullBearBres: $PFE & $SGMO ?? Pfizer & Sangamo Announce Phase 3 Trial of Investigational Gene Therapy for Hemophilia A Has Re-Opened R… September 23rd 2022, 4:09am |
 |
@BullBearBres $PFE & $SGMO ?? Pfizer & Sangamo Announce Phase 3 Trial of Investigational Gene Therapy for Hemophilia A Has Re-Op… https://t.co/2oJ8TDrTKP September 23rd 2022, 4:09am |
|
@MarcJacksonLA $PFE $SGMO Pfizer and Sangamo Therapeutics Announce Phase 3 Trial of Investigational Gene Therapy for Hemophilia A… https://t.co/f65Ccbvw1w September 23rd 2022, 1:09am |
 |
@BiotechAnalysst RT @MarketCurrents: $PFE $SGMO - Pfizer, Sangamo reopen recruitment for late-stage trial of hemophilia A gene therapy https://t.co/9mzV2BHx… September 22nd 2022, 11:09pm |
 |
@MarketCurrents $PFE $SGMO - Pfizer, Sangamo reopen recruitment for late-stage trial of hemophilia A gene therapy https://t.co/9mzV2BHxya September 22nd 2022, 9:09pm |
 |
@quantisnow $SGMO ? Sangamo Therapeutics Inc. filed SEC Form 8-K: Other Events https://t.co/zS7y0gDVEO 45 seconds delayed. September 22nd 2022, 9:09pm |
|
@TradeWithAlerts Nice print for $SGMO Size: 161897 Price: 5.04 Amount: $815,960.88 Time: 1600 See more: https://t.co/hnsHyqewlx Join… https://t.co/usVfFgDcT1 September 22nd 2022, 8:09pm |
|
@BiotechAnalysst RT @BiotechAnalysst: Buying $sgmo sub 5 ! September 22nd 2022, 6:09pm |
|
@BiotechAnalysst RT @BiotechAnalysst: $SGMO Fabry trial updated too: expanding into Australia, Italy, Canada Experimental: Expansion Cohorts Anti Alpha… September 22nd 2022, 6:09pm |
|
@BiotechAnalysst $SGMO Fabry trial updated too: expanding into Australia, Italy, Canada Experimental: Expansion Cohorts Anti Al… https://t.co/abrBdPfn7p September 22nd 2022, 4:09pm |
|
@BiotechAnalysst Buying $sgmo sub 5 ! https://t.co/J4ABtE29oA September 22nd 2022, 1:09pm |
 |
@BiotechObserver @kernytsky @NatHarooni This thread doesn't concern $SGMO or them needing to get anything right, though lol September 22nd 2022, 12:09am |
 |
@kernytsky @NatHarooni @BiotechObserver That combined with $SGMO sputtering around for 20 years and producing nothing despite… https://t.co/w4Dnn8iq5y September 22nd 2022, 12:09am |
 |
@mattyjc @mchilberg That sirolimus and rituximab combo will make it very, very hard to for $FDMT to be competitive if $SGMO… https://t.co/cjuAfK3RdP September 21st 2022, 12:09pm |
 |
@BenzingaMedia $PLX, $SGMO Under The Hood Of Options Chain Implications — Understanding How Options Data Can Help Inform - https://t.co/xtlZq2Snwd September 20th 2022, 12:09pm |
 |
@newsfilterio Form 3 (initial statement of beneficial ownership of securities) filed with the SEC $SGMO https://t.co/CqT4c7pv5L September 19th 2022, 11:09pm |
 |
@FlashAlert_me $SGMO [15s. delayed] filed SEC form 3: SVP-Chief Development Officer Dubois-Stringfellow Nathalie: https://t.co/q0fsslasME September 19th 2022, 11:09pm |
 |
@SwingTradeBot 50 DMA Support today: $SGMO $PRCH ... https://t.co/aW7zteLmZs September 19th 2022, 4:09pm |
 |
@Gregory96452458 $SGMO is set and ready for a run up:~ ? https://t.co/3QMEpMlx5p September 19th 2022, 8:09am |
|
@BiotechAnalysst RT @mchilberg: Well said. $SGMO TF regulation and novel delivery are both progressing nicely under the radar. Time will tell but as $NTLA… September 16th 2022, 4:09pm |
 |
@mchilberg Well said. $SGMO TF regulation and novel delivery are both progressing nicely under the radar. Time will tell but… https://t.co/Rx7hfv5y98 September 16th 2022, 4:09pm |
|
@mattyjc @iamseanmcd @CarterBWorth Oh you’ve heard of my $SGMO hodl strategy, I see? https://t.co/CRlQt9ZcKX September 16th 2022, 1:09pm |
|
@mattyjc ZFPs for treatment of prion disease (in mice) $SGMO https://t.co/FAQ8gsZl2a September 15th 2022, 4:09pm |
 |
@Biotech2050 RT @BiotechAnalysst: $SGMO Abstract reducing Prion : " ZF-TFs can substantially lower PrP in the #brain, extend #survival, and #alter disea… September 15th 2022, 4:09pm |
|
@BiotechAnalysst $SGMO Abstract reducing Prion : " ZF-TFs can substantially lower PrP in the #brain, extend #survival, and #alter di… https://t.co/i1RjcEYMRn September 15th 2022, 2:09pm |
|
@BiotechAnalysst RT @bio_2022: $SGMO another forgotten name just ramp above 30 weeks moving avg and consolidate back to 9 weeks moving avg. A 1st pullback t… September 15th 2022, 1:09pm |
|
@BiotechAnalysst RT @mchilberg: Bottom line: $SGMO preliminary data appears very strong and the clinical design has provided an exceptional foundation that… September 15th 2022, 1:09pm |
|
@BiotechAnalysst RT @mchilberg: $SGMO ST-920 has completed dose finding studies and is now in cohort expansion. Yesterday SM stated that they decided to eli… September 15th 2022, 1:09pm |
|
@BiotechAnalysst RT @mchilberg: $SGMO study appears exceptionally well designed. They have a mix of on-ERT, off-ERT and ERT-naive patients enrolled with ea… September 15th 2022, 1:09pm |
|
@BiotechAnalysst $SGMO Gene Therapy for Adults with Severe Hemophilia A, to Provide Substantial #Cost #Savings Per Patient September 15th 2022, 1:09pm |
 |
@bio_2022 $SGMO another forgotten name just ramp above 30 weeks moving avg and consolidate back to 9 weeks moving avg. A 1st… https://t.co/zGqdgs2F1t September 15th 2022, 7:09am |
|
@mchilberg $SGMO has minimized the possibility of accel approval. $VRTX discussion recently on VX147 for APOL-1 is worth a li… https://t.co/k7EqJhdMAX September 14th 2022, 10:09pm |
|
@mchilberg Bottom line: $SGMO preliminary data appears very strong and the clinical design has provided an exceptional founda… https://t.co/KBTuWnhZVK September 14th 2022, 10:09pm |
|
@mchilberg One focus point worth watching is the data on kidney/cardiac disease biomarkers eGFR and cMRI LVM. $SGMO has a Kid… https://t.co/vivynKDUfP September 14th 2022, 10:09pm |
|
@mchilberg A recap of the $SGMO study readouts is attached. Later this year we should get some substantive data on cohort 3-4… https://t.co/M5YLHq3YAW September 14th 2022, 10:09pm |
|
@mchilberg $SGMO study appears exceptionally well designed. They have a mix of on-ERT, off-ERT and ERT-naive patients enrolle… https://t.co/SDINhiyiEW September 14th 2022, 10:09pm |
|
@mchilberg $SGMO ST-920 has completed dose finding studies and is now in cohort expansion. Yesterday SM stated that they decid… https://t.co/rQvZVo10Lg September 14th 2022, 10:09pm |
|
@TradeWithAlerts Nice print for $SGMO Size: 632849 Price: 5.59 Amount: $3,537,625.91 Time: 1600 See more: https://t.co/hnsHyqewlx Jo… https://t.co/GIhZj1KCB5 September 14th 2022, 8:09pm |
 |
@ChartMill $SGMO is expected to show quite a strong growth in Revenue, Revenue will grow by 10.45% yearly.… https://t.co/fJ8pPnA0J9 September 14th 2022, 12:09pm |
|
@mchilberg $SGMO at HC Wainwright today. Mostly a repeat https://t.co/iKMIgqWmWI September 12th 2022, 6:09pm |
|
@SwingTradeBot 20 DMA Support today: $SGMO $NRSN ... https://t.co/deOpbNqLGE September 9th 2022, 7:09pm |
|
@Tickeron $SGMO in Downtrend: RSI indicator exits overbought zone. View odds for this and other indicators:… https://t.co/66Alieqsog September 2nd 2022, 6:09pm |
 |
@SADIFAnalytics Will Sangamo Therapeutics Inc Deliver Top-Shelf Performance? $SGMO https://t.co/PZiBWo0qWE September 2nd 2022, 3:09pm |
 |
@MitchellReed09 RT @mchilberg: Next step to enroll 6 participants in 6 different cohorts??? Need to fact check this article $SGMO September 2nd 2022, 2:09pm |
|
@mchilberg Next step to enroll 6 participants in 6 different cohorts??? Need to fact check this article $SGMO https://t.co/NEm05T7jqb September 2nd 2022, 1:09pm |
DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC
2004 - 2022. All rights reserved.